MENU
ALGS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aligos Therapeutics (ALGS) Ownership - Who owns Aligos Therapeutics?
Profile
Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
66
Web
https://www.aligos.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.7M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
10.49M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
1.65 USD as % of share price
Fundamentals
ALGS
Capitalization
25.7M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
10.5M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.65%
Revenue
N/A
ROE
N/A
Book Value
59.8M
P/B Ratio
0.38
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
6.25
Current Revenue Per Employee
14716.42
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
3.2M
Total Liabilities
68.1M
Total Volume MTD
N/A
Value
1
Gain YTD
-27.892
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
One Corporate Drive
Phone
+1 800 466-6059
Employees
66
Web
https://www.aligos.com